US$ 24.72
glp 1 generic drugs Comparing Ozempic, Wegovy and Other GLP-1 GLP-1 Drugs from the Gray
Description
Across the 11 included studies, 91,490 participants were analysed

Obesity, Type 2 Diabetes, and Cancer Risk

10.2337/dc14-2548 69

C., et al

The studys limitations include its reliance on a US sample and a retrospective design, which may introduce bias and limit generalizability

In addition, post-hoc sensitivity analyses were performed by excluding the prediabetic population (SELECT trial [8]) in Fig